Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications studying cancer adverse outcome nononcological therapies review food drug
Women's Health A Wealth of Experience We have collaborated with our clients on projects researching women's health, diseases related to women's health, or complications of treatment in women's health. Our experience includes: Cervical dystonia …
Decision-Analytic Model to Estimate Costs and Outcomes for Additional Screening for Ischemic Stroke Treatment OPPORTUNITY Our client wanted to understand if the costs of adding computed tomography perfusion ( CTP) or magnetic resonance imaging (MRI) to …
Case Studies Learn more about our experience and expertise. Read our case studies. …
… in patients with inadequate response to disease-modifying therapies in relapsing-remitting multiple sclerosis in the …
… and post hoc) on patient-reported quality of life data and adverse event data from clinical trials, exploratory … and hematology (breast, colorectal, gastric, and kidney cancer; follicular lymphoma; and myelofibrosis), chronic … health. Dr. Zhou has been responsible for statistical review or writing of protocols, authoring statistical …
… in large population-based cohorts for the National Cancer Institute. He has a long-standing interest is cancer epidemiology. Since joining RTI HS in 2005, he has … natural history and incidence of and risk factors for rare adverse outcomes potentially associated with use of …
… impacts of COVID-19 on the collection and use of clinical outcome assessment (COA) data. They drew on current FDA recommendations for patient-focused drug development (PFDD) and other more emergent regulatory …
… development and implementation; patient-reported outcome strategy; large scale survey development and implementation; and a thorough understanding of the Food and Drug Administration (FDA) patient-focused drug development …
… Research Analyst for the Mississippi Evidence-based Drug Utilization Review (MS-DUR) Initiative at the University of Mississippi. … disorders, diabetes, inflammatory bowel disease, and cancer. She has worked with diverse data sources including …
… Editing, and Design Services Barcelona, Spain PhD, Cancer Immunotherapy-Applied Medicine University of Navarra, … more than 8 years of research experience. She has lead drug development pipelines for RNA therapeutics (Aptamers), CD3 Bispecifics, T-cell–based therapies (CARs, TCR T-cells, and adoptive T -cell …